Strata Critical Medical (SRTA) Stock: Buy, Sell, or Hold?
SRTA - Strata Critical Medical, Inc. Class A Common Stock
$4.66
-0.05 (-1.06%)
▼
5d:
+2.64%
30d:
-11.57%
90d:
-9.34%
BUY
MODERATE Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 09, 2026
16d
Get Alerted When SRTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SRTA shows positive signals but monitor for confirmation. Market pricing in 183.8% growth. Moderate conviction.
💡 BUY OPPORTUNITY: SRTA shows positive signals but monitor for confirmation. Market pricing in 183.8% growth. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SRTA is currently trading at $4.66, which is considered oversold relative to its 30-day fair value range of $4.58 to $5.33. From a valuation perspective, the stock is trading at a premium (Forward PE: 1427.3) compared to its historical average (62.4). At these levels, the market is pricing in 183.8% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, SRTA is in a downtrend. The price is approaching resistance at $4.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SRTA scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $9.56 (+103.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SRTA is in a downtrend. The price is approaching resistance at $4.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SRTA scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $9.56 (+103.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.58 -
$5.33
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
85.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (67/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 103.0% below Wall St target ($9.56)
- BEARISH: Market expects 183.8% growth - appears too optimistic based on history
- BULLISH: Bottoming setup score 67/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$4.58 -
$5.33
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.21
Resistance Level
$4.79
Current Trend
Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1427.27
Wall Street Target
$9.56
(+103.0%)
Revenue Growth (YoY)
60.7%
Profit Margin
15.7%
Valuation Premium vs History
+183.8% premium
PE vs Historical
1427.3 vs 62.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+183.8%
(market-implied from PE analysis)
1-Year Target
$7.06
(+50%)
2-Year Target
$10.60
(+125%)
3-Year Target
$15.90
(+238%)
3-Yr Target (if PE normalizes)
(PE: 1427→62)
PE COMPRESSION
$0.69
(-85%)
Significant PE compression expected
Share & Embed Analysis
Last updated: October 23, 2026 4:00 PM ET
Data refreshes hourly during market hours. Next update: 5:00 PM
Data refreshes hourly during market hours. Next update: 5:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$286 | 51 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$461 | 49 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$148 | 61 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 50 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
14 analysts |
$134 | 54 HOLD |